Status: Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
Participants needed: 285
Trial details
Phase: Phase 3Age: 12-17Biological sex: AllType: InterventionalSponsor: H. Lundbeck A/SUpdated: Jun 12, 2026Locations: 84
Eligibility criteria
The participant has a diagnosis of migraine (with or without aura) as defined by... [+2]
The participant has previously been randomised in this study and exposed to epti... [+3]